sertraline has been researched along with Premenstrual Dysphoric Disorder in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Epperson, CN; Grillon, C; Hantsoo, L; Johnson, R; Marks, J; Sammel, M | 1 |
| Kamagata, E; Yamada, K | 1 |
| Altemus, M; Gueorguieva, R; Kornstein, SG; Merry, B; Van Steenburgh, K; Yonkers, KA | 1 |
1 trial(s) available for sertraline and Premenstrual Dysphoric Disorder
| Article | Year |
|---|---|
Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.
Topics: Adult; Anger; Depression; Double-Blind Method; Female; Humans; Irritable Mood; Luteal Phase; Premenstrual Dysphoric Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Outcome | 2015 |
2 other study(ies) available for sertraline and Premenstrual Dysphoric Disorder
| Article | Year |
|---|---|
Response to sertraline is associated with reduction in anxiety-potentiated startle in premenstrual dysphoric disorder.
Topics: Anxiety; Anxiety Disorders; Female; Humans; Menstrual Cycle; Premenstrual Dysphoric Disorder; Premenstrual Syndrome; Sertraline | 2021 |
Improvements in Quality-Adjusted Life Years and Cost-Utility After Pharmacotherapy for Premenstrual Dysphoric Disorder: A Retrospective Study.
Topics: Adolescent; Adult; Citalopram; Cost-Benefit Analysis; Female; Humans; Middle Aged; Premenstrual Dysphoric Disorder; Quality-Adjusted Life Years; Retrospective Studies; Sertraline; Young Adult | 2018 |